Back

The IUCT Oncopole designated once again for early phase trials


The IUCT Oncopole designated once again for early phase trials

The National Cancer Institute (INCa) has renewed the designation of the ICR Clinical Research Unit for  early phase clinical research *, led by Prof. Jean-Pierre Delord. This designation covers the period 2014 -2019.


* Early trials include Phase I and Phase II trials.

Phase I trials are designed to evaluate a new drug (or drug combination) to determine the recommended administration dose; they are proposed only when no existing treatment is entirely satisfactory. Phase II trials essentially measure the efficacy of a new treatment method (a drug or a new combination of drugs).

Find out more about designated early-phase clinical trial centers: link